TB 500 2mg

TB-500 and thymosin-related research

TB-500 2mg is associated with the thymosin beta-4 research field, which explores the relationship between peptide structure, cellular movement and tissue responses. Direct TB-500 studies also provide useful analytical information about fragment identity and metabolism.

The fragment studied in the literature

Researchers have identified N-acetylated LKKTETQ in a preparation called TB-500. This seven-amino-acid sequence corresponds to residues 17-23 within thymosin beta-4. Establishing that structure allows experimental findings to be connected to a defined molecule, rather than relying on a product name alone.

In equine research, liquid chromatography and mass spectrometry detected the fragment and its metabolites after administration. The work contributes to understanding peptide breakdown and provides methods for recognising the material in biological samples.

Connecting the research to this listing

TB-500 is also used commercially in association with full-length thymosin beta-4. The supplied information for this 2mg vial does not include sequence-level confirmation, so the fragment and full-length identities are kept distinct here.

Cell-movement and repair research involving the parent peptide provides scientific background, while claims about human recovery require direct evidence for the actual material. The 2mg amount identifies this quantity variant without implying a different biological action.

Also known as / branded as

• TB-500
• TB500